The review of the international literature on the hexavalent vaccination adverse effects, documents, without doubt, the existence of a new clinical syndrome: “The Post Hexavalent Vaccination Sudden Infant Death Syndrome ”, (PHVSIDS) without concurrent pathologies inducing a life risk confirmed by autoptic investigation, with an enhancement of the infant mortality and hospital admissions rates correlated to the number of vaccines before the first year of life.From 1999 to 2004, in Italy, there has been a slaughter of 52 infant deaths directly associated to hexavalent vaccination , 8 before 24 hours (RR= 1,5, RR= 2,3 with the Infarix Hexa vaccine- 0,7 with Hexavac ) , 34 within 7 days (RR=1,8- RR 1,5 with Infarix Hexa- 2,8 with Hexavac, with all the hexavalent products RR =2) 52 within 14 days (RR 1,5, RR= 1,5 with Infarix Hexa,1,6 with Hexavac). Children’s deaths notifications continued after this date. The hexavalent vaccination appears like a Russian Roulette in children with an unknown vulnerability. In addition to PHVSDS, there is the clinical and scientific evidence of auto-immune diseases, associated to vaccinations that derive from minerals added to vaccines as adjuvants, preservatives and stabilizers, like Aluminum , inoculated in enormous quantity, and Mercurium, that allows to define a new clinical Syndrome: the Post Vaccination ASIA Syndrome-PVAS). ASIA is the depicted Autoimmunity Syndrome Induced by Adjuvants . Moreover, there is an irrefutable documentation that hexavalent vaccination determines immunosuppression well depicted by immunology, a consequent cause of death from other infections, as happened .

The philosophy: " “ Let few deaths for saving much more lives " is unacceptable for a clinician, when in Public Health other preventive solutions are possible.

(From

The hexavalent vaccination Russian Roulette

The hexavalent vaccination risk for children’s and adults life . The introduction of The Post Hexavalent Vaccination Sudden Death Syndrome (PHVSIDS) and the Post Vaccination Asia Syndrome( PVAS). in Research Gate)